Free Trial

Genmab A/S (GNMSF) Earnings Date, Estimates & Call Transcripts

Genmab A/S logo
$210.76 -1.95 (-0.92%)
(As of 11/18/2024 ET)
Get Genmab A/S Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Genmab A/S and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

GNMSF Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

GNMSF Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Genmab A/S Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
8/8/2024Q2 2024-$3.13+$3.13$3.13-$779.50M
5/2/2024Q1 2024-$2.94+$2.94$2.94-$603.22M
2/14/2024Q4 2023-$3.63+$3.63$5.85-$675.29M
11/7/2023Q3 2023-$4.72+$4.72$4.72-$692.80M
8/3/2023Q2 2023-$3.01+$3.01$3.01-$613.43M
5/10/2023Q1 2023-$0.49+$0.49$0.49-$411.37M
2/22/2023Q4 2022-$1.21+$1.21$1.21-$717.54M


This page (OTCMKTS:GNMSF) was last updated on 11/19/2024 by MarketBeat.com Staff
From Our Partners